cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Taro Pharmaceutical Industries Ltd
3 own
7 watching
Current Price
$36.86
$0.83
(2.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,473.04M
52-Week High
52-Week High
42.22000
52-Week Low
52-Week Low
22.89000
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
11.4465
iconMarket Capitalization1,473.04M
icon52-Week High42.22000
icon52-Week Low22.89000
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio11.4465
What does the Taro Pharmaceutical Industries Ltd do?
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Sun Pharmaceutical Industries Ltd.
Read More
News & Events about Taro Pharmaceutical Industries Ltd.
Business Wire
5 months ago
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023, filed with the Securities and Exchange Commission (the...
Ticker Report
6 months ago
Taro Pharmaceutical Industries (NYSE:TARO Get Rating) was downgraded by investment analysts at StockNews.com from a buy rating to a hold rating in a report released on Wednesday. Separately, HC Wainwright decreased their price objective on shares of Taro ...
Zolmax
7 months ago
StockNews.com downgraded shares of Taro Pharmaceutical Industries (NYSE:TARO Get Rating) from a buy rating to a hold rating in a research note issued to investors on Wednesday. Separately, HC Wainwright cut their price target on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy ...
Business Wire
1 year ago
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2022, after the close of market on Thursday, October 27, 2022. The release will be accessible on Taros website at www.taro.com. About Taro Taro...
Frequently Asked Questions
Frequently Asked Questions
What is Taro Pharmaceutical Industries Ltd share price today?
plus_minus_icon
Can Indians buy Taro Pharmaceutical Industries Ltd shares?
plus_minus_icon
How can I buy Taro Pharmaceutical Industries Ltd shares from India?
plus_minus_icon
Can Fractional shares of Taro Pharmaceutical Industries Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Taro Pharmaceutical Industries Ltd stocks?
plus_minus_icon
What is today’s traded volume of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What is today’s market capitalisation of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What percentage is Taro Pharmaceutical Industries Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Taro Pharmaceutical Industries Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$36.86
$0.83
(2.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$22.20
$0.00 (0.00 %)
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
$39.11
$0.65 (1.69 %)
Prestige Brands Holdings Inc
Prestige Brands Holdings Inc
$57.00
$-0.13 (-0.23 %)
Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Inc
$26.94
$-0.03 (-0.11 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$22.20
$0.00 (0.00 %)
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
$39.11
$0.65 (1.69 %)
Prestige Brands Holdings Inc
Prestige Brands Holdings Inc
$57.00
$-0.13 (-0.23 %)
Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Inc
$26.94
$-0.03 (-0.11 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00